| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/09/2004 | WO2004106870A1 Measuring device for nondestructively determining the weight-in quantity in capsules |
| 12/09/2004 | WO2004106542A1 Insulin resistance curative and method of screening the same |
| 12/09/2004 | WO2004106540A1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils) |
| 12/09/2004 | WO2004106537A1 Method of detecting cancerous cell |
| 12/09/2004 | WO2004106535A2 Enhanced cellular assay method for use in flow cytometry or similar instruments using optically resonant particles |
| 12/09/2004 | WO2004106515A1 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer containing the same |
| 12/09/2004 | WO2004106512A1 Method of enhancing pathogen-resistance of plant |
| 12/09/2004 | WO2004106500A1 Method for increasing the yield of proliferating primary keratinocytes |
| 12/09/2004 | WO2004106497A2 Imageable animal model of sars infection |
| 12/09/2004 | WO2004106495A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 12/09/2004 | WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 12/09/2004 | WO2004106385A2 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 12/09/2004 | WO2004106368A1 Generation of artificial binding proteins based on ubiquitin proteins |
| 12/09/2004 | WO2004106367A2 Enterococcus antigens |
| 12/09/2004 | WO2004106366A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 12/09/2004 | WO2004106357A1 Method and apparatus for recognizing molecular compounds |
| 12/09/2004 | WO2004105793A2 Soluble clca-1 and antagonists to clca-1 |
| 12/09/2004 | WO2004105785A2 Use of pam |
| 12/09/2004 | WO2004105773A2 Use of s1p |
| 12/09/2004 | WO2004105681A2 Cd4+ human papillomavirus (hpv) epitopes |
| 12/09/2004 | WO2004105575A2 A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| 12/09/2004 | WO2004105573A2 Method of diagnosis of cancer based on gene expression profiles in cells |
| 12/09/2004 | WO2004096021A3 Global analysis of transposable elements as molecular markers of cancer |
| 12/09/2004 | WO2004093919A3 Target for cancer therapy and drug discovery |
| 12/09/2004 | WO2004089990A9 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 12/09/2004 | WO2004087966A3 Genomic profiling of regulatory factor binding sites |
| 12/09/2004 | WO2004087944A8 Improvements in or relating to viability |
| 12/09/2004 | WO2004083851A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| 12/09/2004 | WO2004083462A3 Replication assay for discovering antiviral substances using a high throughput screening (hts) method |
| 12/09/2004 | WO2004083436A9 Novel bt toxin receptors and methods of use |
| 12/09/2004 | WO2004079329A3 Identification of therapeutic compounds |
| 12/09/2004 | WO2004079326A3 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 12/09/2004 | WO2004078175A3 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases |
| 12/09/2004 | WO2004077015A3 Method for analysis of contaminants in a process fluid stream |
| 12/09/2004 | WO2004077010A3 Water channel assays |
| 12/09/2004 | WO2004074320A8 Therapeutic targets in cancer |
| 12/09/2004 | WO2004069194A9 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 12/09/2004 | WO2004067725A3 Methods of identifying modulators of nmur2-mediated activity |
| 12/09/2004 | WO2004062572A3 Determining the density of functional moieties on polymer reagents |
| 12/09/2004 | WO2004061123A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 12/09/2004 | WO2004061084A8 Modulation of protein functionalities |
| 12/09/2004 | WO2004060262A3 Modulators of notch signalling for use in immunotherpapy |
| 12/09/2004 | WO2004058703A3 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 12/09/2004 | WO2004050828A3 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 12/09/2004 | WO2004048929A3 High throughput screening with parallel vibrational spectroscopy |
| 12/09/2004 | WO2004047759A3 Composition for treating chlamydia infections and method for identifying same |
| 12/09/2004 | WO2004046684A3 Mixed potential hydrocarbon sensor with low sensitivity to methane and co |
| 12/09/2004 | WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 12/09/2004 | WO2004042074A3 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 12/09/2004 | WO2004038379A3 Techniques for analyzing products containing a coloring agent |
| 12/09/2004 | WO2004038363A3 Microfluidic device and method for pressure-driven plug transport and reaction |
| 12/09/2004 | WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 12/09/2004 | WO2004030826A3 Buffy coat separator float system and method |
| 12/09/2004 | WO2004020981A3 Methods of screening cyclic peptides and identifying targets therefor |
| 12/09/2004 | WO2004017728A3 Methods |
| 12/09/2004 | WO2004017042A3 Methods and reagents for surface functionalization |
| 12/09/2004 | WO2004006866A3 Antifungal therapeutic targets |
| 12/09/2004 | WO2004005531A3 Targeting and tracking of cells to specific organs and tissues in vivo |
| 12/09/2004 | WO2003106624A3 Cancer-linked gene as target for chemotherapy |
| 12/09/2004 | WO2003106623A3 Early noninvasive prenatal test for aneuploidies and heritable conditions |
| 12/09/2004 | WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 12/09/2004 | WO2003102018A3 Methods for quantitative proteome analysis of glycoproteins |
| 12/09/2004 | WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/09/2004 | WO2003101401A3 Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
| 12/09/2004 | WO2003081506A3 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers |
| 12/09/2004 | WO2003080808A3 Novel compositions and methods in cancer |
| 12/09/2004 | WO2003063763A3 Complement mediated assays for in vivo and in vitro methods |
| 12/09/2004 | WO2003062793A3 Analysis device |
| 12/09/2004 | WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies |
| 12/09/2004 | WO2003043568A3 Compositions and methods for the suppression of mammary epithelial cell proliferation |
| 12/09/2004 | WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker |
| 12/09/2004 | US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
| 12/09/2004 | US20040250299 Compound screening method |
| 12/09/2004 | US20040250298 Methods for selecting and screening for transformants |
| 12/09/2004 | US20040249654 Smart data subsurface data repository system, method and computer program product |
| 12/09/2004 | US20040249591 Method for monitoring the properties of pharmaceutical articles |
| 12/09/2004 | US20040249586 Molecular modification assays |
| 12/09/2004 | US20040249578 Nox software sensor |
| 12/09/2004 | US20040249577 Method and apparatus for identifying components of a system with a response acteristic |
| 12/09/2004 | US20040249576 Methods for rational pegylation of proteins |
| 12/09/2004 | US20040249332 collection efficiency, reduce platelet activation of the apheresis system; collection of plasma and red blood cells may occur simultaneously or subsequently utilizing the same dual stage blood processing vessel |
| 12/09/2004 | US20040249310 Micro-piercing member used to penetrate the skin to a selected depth and to access biological fluid, a constituent sampling means and a constituent measuring means |
| 12/09/2004 | US20040249254 Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
| 12/09/2004 | US20040249253 Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
| 12/09/2004 | US20040249227 Biosensor and method for detecting analytes by means of time-resolved luminescene |
| 12/09/2004 | US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248976 A DNA fragment probe is used to bind specifically to a target substance; a moisturizer is used to spot the probe to be fixed on a substrate, promote omission, stabilizing the spot shape, increase detection sensitivity of a reaction chip |
| 12/09/2004 | US20040248909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairment |
| 12/09/2004 | US20040248869 Contacting cell culture capable of metabolism; calibration |
| 12/09/2004 | US20040248851 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes |
| 12/09/2004 | US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders |
| 12/09/2004 | US20040248801 Multivalent ligands which carry or display at least one recognition element (RE), for binding directly or indirectly to cells or other biological particles; applicable for creating scaffolds of chemical/biological species |
| 12/09/2004 | US20040248800 Crystals and structures of epidermal growth factor receptor kinase domain |
| 12/09/2004 | US20040248791 Insect g protein-coupled receptor genes and uses thereof |
| 12/09/2004 | US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/09/2004 | US20040248781 Therapeutic method for reducing angiogenesis |
| 12/09/2004 | US20040248775 Methods for screening inhibitors of apoptosis |
| 12/09/2004 | US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same |